相关实验视频

Updated: Jul 9, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

治疗性的融合蛋白质

Morgan C Marsh¹, Shawn C Owen^2,3,4

¹Department of Molecular Pharmaceutics, University of Utah, 30 South 2000 East, Room 301, Salt Lake City, Utah, 84112, USA.

The AAPS journal

|November 30, 2023

概括

治疗性融合蛋白结合生物分子,改善疾病治疗. 这些多功能结构提供了更长的半衰期,有针对性的输送和持续的信号,为各种生物制药应用铺平了道路.

科学领域:

生物技术和制药科学生物技术和制药科学
分子生物学与工程分子生物学与工程

背景情况:

治疗融合蛋白是一种混合生物分子结构,旨在将不同的功能结合到单一的治疗剂中.
它们的发展利用了蛋白质工程和抗体技术的进步,创造了新的治疗方式.
已确定的应用包括延长半衰期,增强药物暴露和疗效,并取得了众多临床成功.

研究的目的:

探索治疗疾病治疗中的治疗融合蛋白的多样化应用和潜力.
突出这些工程生物分子的设计原则和功能能力.
为了强调融合蛋白超越瘤学的扩大范围,进入各种治疗领域.

主要方法:

通过融合不同的生物分子,如蛋白质和抗体衍生物的混合结构的工程.
融合蛋白的设计,以实现特定的治疗功能,如延长半衰期,有针对性的输送和持续的信号传输.
利用癌症治疗现有的成功,探索在其他疾病中的应用.

主要成果:

融合蛋白质可以通过组合生物分子的添加效应来设计,以定位治疗机制.
半衰期延长是一个成熟的功能,具有重要的临床验证.
新兴的设计包括双重活性功能和针对高级治疗策略的目标领域.

结论:

治疗融合蛋白提供了一个多功能平台,用于开发跨多种疾病的新疗法.
生物制药领域的持续研发将推动融合蛋白设计和应用方面的创新.
融合蛋白的适应性将它们定位为未来治疗进步的关键领域.

关键词:

生物学是生物学的学科.聚变蛋白质的融合蛋白质治疗蛋白质的治疗蛋白质.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tagging and Fusion Proteins

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...